Treatment Selection and Sequencing Strategies in HER2+ Metastatic Breast Cancer : Episode 9

Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

April 7, 2025

Opinion

Video

Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.

EP: 1.Treatment Selection and Sequencing in Third Line Settings and Beyond

EP: 2.Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

EP: 3.Managing Toxicity in Later-Line HER2+ mBC Treatments: Real-World Insights and Mitigation Strategies for Optimal Patient QOLs

EP: 4.Supporting HER2+ mBC Patients in Later Lines: AE Management and the Role of the Multidisciplinary Team

EP: 5.Treatment Goals, Side Effects, and Supportive Care Strategies for Patients and Caregivers with HER2+ BC

EP: 6.Barbara's Story: Navigating HER2+ MBC with Brain Metastases & Tucatinib-Based Treatment in the Second-Line Setting

EP: 7.Evolving Treatment Strategies in Early HER2+ Breast Cancer

EP: 8.Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine

Now Viewing

EP: 9.Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

Video content above is prompted by the following:

What have been your care strategies for brain metastasis that are beneficial for the patients and their families.

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!